Treatment for nerve-poisoning agents.
D000931:Antidotes / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use*; D002619:Chemical Warfare Agents / Q000506:poisoning*; D017277:Drug Approval; D004338:Drug Combinations; D006801:Humans; D011220:Pralidoxime Compounds / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000931:Antidotes; D002619:Chemical Warfare Agents; D004338:Drug Combinations; D011220:Pralidoxime Compounds; C517983:duodote; D001285:Atropine